Classical hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation

Haematologica

Volumn 96, Issue 6, 2011, Pages 863-870

  Seitz, Volkhard ^a   Thomas, Philippe E ^b   Zimmermann, Karin ^b   Paul, Ulrike ^a   Ehlers, Anke ^a   Joosten, Maria ^a   Dimitrova, Lora ^a   Lenze, Dido ^a   Sommerfeld, Anke ^a   Oker, Elisabeth ^a   Leser, Ulf ^b   Stein, Harald ^a   Hummel, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Acetylation; B cell lymphoma; Epigenetics; Hodgkin's lymphoma; Multiple myeloma

Indexed keywords

BINDING PROTEIN; HISTONE H3; INTERFERON REGULATORY FACTOR 4;

ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IRF4 GENE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PLASMA CELL; RYBP GENE;

ACETYLATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DEOXYCYTIDINE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HODGKIN DISEASE; HUMANS; HYDROXAMIC ACIDS; PLASMA CELLS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS;

EID: 79958053629     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.031138     Document Type: Article

References (48)

1. Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer. 2005;41(16):2381-402.
2. Jain N, Rossi A, Garcia-Manero G. Epi - genetic therapy of leukemia: an update. Int J Biochem Cell Biol. 2009;41(1):72-80.
3. Buglio D, Georgakis GV, Hanabuchi S, Arima K, Khaskhely NM, Liu YJ, et al. Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. Blood. 2008;112(4):1424-33.
4. Crump M, Coiffier B, Jacobsen ED, Sun L, Ricker JL, Xie H, et al. Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Ann Oncol. 2008;19(5):964-9.
5. Watanabe T, Kato H, Kobayashi Y, Yamasaki S, Morita-Hoshi Y, Yokoyama H, et al. Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma. Cancer Sci. 2010;101(1):196-200.
6. Kerppola TK. Polycomb group complexes- -many combinations, many functions. Trends Cell Biol. 2009;19(12):692-704.
7. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature. 1978;276 (5688):565-70.
8. Raaphorst FM, van Kemenade FJ, Fieret E, Hamer KM, Satijn DP, Otte AP, et al. Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol. 2000;164(1):1-4.
9. Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol. 2003;4(2):124-31.
10. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010; 42(2):181-5.
11. Vaissiere T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008;659(1-2):40-8.
12. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci USA. 2008;105(35):12979-84.
13. Hummel M, Marafioti T, Ziemann K, Stein H. Ig rearrangements in isolated Reed- ternberg cells: conclusions from four different studies. Ann Oncol. 1996;7 (Suppl 4):31-3.
14. Seitz V, Hummel M, Marafioti T, Anagno-Stopoulos I, Assaf C, Stein H. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood. 2000;95 (10):3020-4.
15. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC, 2008.
16. Schwering I, Brauninger A, Klein U, Jungnickel B, Tinguely M, Diehl V, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed- Sternberg cells of Hodgkin lymphoma. Blood. 2003;101(4):1505-12.
17. Ehlers A, Oker E, Bentink S, Lenze D, Stein H, Hummel M. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype. Leukemia. 2008; 22(4):835-41.
18. Buettner M, Greiner A, Avramidou A, Jack HM, Niedobitek G. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Hematol Oncol. 2005;23(3- 4):127-32.
19. Shapiro-Shelef M, Calame K. Plasma cell differentiation and multiple myeloma. Curr Opin Immunol. 2004;16(2):226-34.
20. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9(1):15-27.
21. Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and mi - cro array-based analysis of protein location. Nat Protoc. 2006;1(2):729-48.
22. Detich N, Bovenzi V, Szyf M. Valproate induces replication-independent active DNA demethylation. J Biol Chem. 2003; 278(30):27586-92.
23. Weishaupt H, Sigvardsson M, Attema JL. Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood. 2010;115(2):247-56.
24. Bookout AL, Mangelsdorf DJ. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal. 2003;1:e012.
25. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, Brown M, et al. Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci USA. 2006;103(33):12457-62.
26. Weigelt K, Moehle C, Stempfl T, Weber B, Langmann T. An integrated workflow for analysis of ChIP-chip data. Biotechniques. 2008;45(2):131-2, 4, 6 passim.
27. Smyth GK, Yang YH, Speed T. Statistical issues in cDNA microarray data analysis. Methods Mol Biol. 2003;224:111-36.
28. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):P3.
29. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
30. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1-2):279-84.
31. Smedley D, Haider S, Ballester B, Holland R, London D, Thorisson G, et al. BioMart-- biological queries made easy. BMC Genomics. 2009;10:22.
32. Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A, et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005;21(16):3439-40.
33. Brune V, Tiacci E, Pfeil I, Doring C, Eckerle S, van Noesel CJ, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205(10):2251-68.
34. Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, et al. IRF4 addiction in multiple myeloma. Nature. 2008;454(7201): 226-31.
35. Valsami S, Pappa V, Rontogianni D, Kontsioti F, Papageorgiou E, Dervenoulas J, et al. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4. Haematologica. 2007;92(10):1343-50.
36. Re D, Muschen M, Ahmadi T, Wicken-Hauser C, Staratschek-Jox A, Holtick U, et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res. 2001;61(5):2080-4.
37. Ushmorov A, Ritz O, Hummel M, Leit-Hauser F, Moller P, Stein H, et al. Epigenetic silencing of the immunoglobulin heavychain gene in classical Hodgkin lymphomaderived cell lines contributes to the loss of immunoglobulin expression. Blood. 2004; 104(10):3326-34.
38. Irsch J, Wolf J, Tesch H, Diehl V, Radbruch A, Staratschek-Jox A. Class switch recombination was specifically targeted to immu - noglobulin (Ig)G4 or IgA in Hodgkin's disease- derived cell lines. Br J Haematol. 2001;113(3):785-93.
39. Mollaki V, Georgiadis T, Tassidou A, Ioannou M, Daniil Z, Koutsokera A, et al. Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate- gene association study. J Hum Genet. 2009;54(11):655-9.
40. Doerr JR, Malone CS, Fike FM, Gordon MS, Soghomonian SV, Thomas RK, et al. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines. J Mol Biol. 2005;350 (4):631-40.
41. Ushmorov A, Leithauser F, Sakk O, Weinhausel A, Popov SW, Moller P, et al. Epigenetic processes play a major role in Bcell- specific gene silencing in classical Hodgkin lymphoma. Blood. 2006;107(6): 2493-500.
42. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol. 2006; 7(2):207-15.
43. Aldinucci D, Celegato M, Borghese C, Colombatti A, Carbone A. IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion. Br J Haematol. 2011;152(2):182-90.
44. Kluiver J, Kok K, Pfeil I, de Jong D, Blokzijl T, Harms G, et al. Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma. Hematol Oncol. 2007;25(1):21-9.
45. Sanchez-Beato M, Sanchez E, Gonzalez-Carrero J, Morente M, Diez A, Sanchez- Verde L, et al. Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays. Mod Pathol. 2006;19(5): 684-94.
46. Garcia E, Marcos-Gutierrez C, del Mar Lorente M, Moreno JC, Vidal M. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J. 1999;18(12):3404-18.
47. Sanchez-Beato M, Sanchez E, Garcia JF, Perez-Rosado A, Montoya MC, Fraga M, et al. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. J Pathol. 2004;204(5):528-37.
48. Dukers DF, van Galen JC, Giroth C, Jansen P, Sewalt RG, Otte AP, et al. Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphomaderived cell lines. Am J Pathol. 2004;164(3): 873-81.